China

HanchorBio Licenses Novel CD47 Fusion Protein HCB101 to Henlius in $200 Million+ Regional Deal

HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, annou...

 July 02, 2025 | News

WuXi Biologics Launches WuXiHigh™2.0 to Enable Record-Setting High-Concentration Biologic Formulations

The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces visc...

 July 01, 2025 | News

EVA Pharma and Zhejiang Jinhua CONBA Forge Strategic Alliance to Reinforce Global Healthcare Supply Chains

Two Regional Powerhouses to Strengthen Cross-Border Collaboration for a More Resilient and Accessible Healthcare Supply Chain EVA Pharma, one of the leadi...

 June 30, 2025 | News

Innovent Biologics Secures NMPA Approval for World’s First Dual GCG/GLP-1 Receptor Agonist Mazdutide for Weight Management in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

 June 30, 2025 | News

Mabwell Grants Qilu Pharmaceutical Greater China Rights to Next-Generation Long-Acting G-CSF Albipagrastim Alfa

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its wholly-owned subsidiary T-mab has entered into an ag...

 June 30, 2025 | News

Alebund Pharmaceuticals Achieves Phase 3 Success with AP301 for Hyperphosphatemia in Dialysis Patients

Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal di...

 June 27, 2025 | News

Porton Advanced and EVA Pharma Partner to Boost CAR T-Cell Therapy Manufacturing in the Middle East and Africa

Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies d...

 June 27, 2025 | News

SineuGene Therapeutics Receives FDA Orphan Drug Designation for Gene Therapy SNUG01 in ALS

SineuGene Therapeutics, a clinical-stage biotechnology company focused on gene therapies for neurological diseases, announced that the U.S. Food and Drug A...

 June 27, 2025 | News

EVA Pharma and CHICO Pharmaceutical Join Forces to Localize Oncology API Production for Middle East and Africa

On the sidelines of CPHI China 2025, EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle Eas...

 June 25, 2025 | News

Everest Medicines Releases First Clinical Batch of mRNA Cancer Vaccine EVM14, Advancing Trials in China and the U.S.

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeut...

 June 23, 2025 | News

Harbour BioMed and Otsuka Ink $670M+ Global Deal to Advance Bispecific T-Cell Engager for Autoimmune Diseases

Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology,&nb...

 June 23, 2025 | News

Novo Holdings Showcases Strategic Growth and Impact in Asia with Landmark 2024 Investments

Landmark investments, portfolio progress, and expanded presence positionNovo Holdings for long-term growth and impact in Asia Novo Holdings released ...

 June 20, 2025 | News

Dizal Completes Enrollment for Global Phase III Trial of Sunvozertinib in EGFR exon20ins NSCLC Patients

Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the effi...

 June 20, 2025 | News

Simcere Zaiming Doses First U.S. Patient in Phase 1 Trial of Trispecific Antibody SIM0500 for Relapsed/Refractory Multiple Myeloma

Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group announced the first US patient has started treatment in the ongo...

 June 19, 2025 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close